Biofarmacia
URI permanente para esta comunidad
Examinar
Examinando Biofarmacia por Autor "Alulima Cabrera, Dayana Tairy"
Mostrando 1 - 1 de 1
Resultados por página
Opciones de ordenación
- ÍtemSolo MetadatosCannabis sativa como herramienta terapéutica para el tratamiento de la epilepsia refractaria en latinoamérica(Universidad Católica de Cuenca., 2023) Lliguicota Guaman, Kevin Stalin; Alulima Cabrera, Dayana Tairy; Guillermo Quinde, Juan Israel; 0302196390; 1900812221Introduction: Refractory epilepsy is a public health problem; it affects the neurological development of infants at a cognitive-behavioral level. Therefore, an alternative treatment with Cannabis sativa is considered, showing certain therapeutic benefits. In Latin America, there are 190 reported cases per 100,000 child inhabitants per year, and in Ecuador, between 120 and 165 cases are registered. Objective: To conduct a literature review to determine whether Cannabis sativa can be used as a therapeutic tool to treat refractory epilepsy. Methodology: The population of this study consisted of pediatric patients with refractory epilepsy in Latin America, highlighting countries such as Mexico and Argentina, among others. A qualitative research design was employed, with a descriptive and documentary level, through of a narrative review. The information search used bibliographic sources in scientific journals, books, search engines, and databases. Results: The use of Cannabis sativa is effective in controlling and improving seizure frequencies in patients with refractory epilepsy. However, Cannabis sativa as a therapeutic tool can generate mild and transitory side effects. In Latin America, despite the few studies that corroborate the use of Cannabis in treating refractory epilepsy, it has been associated with a decrease in epileptic seizures and few adverse effects. Conclusion: Cannabis Sativa and its components provide favorable results for treating refractory epilepsy in children. However, aspects such as dosage and possible adverse reactions should be considered.